Pacific Biosciences of California stockPACB
Pacific Biosciences of California trades at $2.43, 29.3% below its 52-week high (Oct 6, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +29.9% year to date, +26.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 18, 2027.
Ratings, candles, signals and the screener for PACB — after you log in
Open the terminalFrequently asked questions about Pacific Biosciences of California
What is the Pacific Biosciences of California stock price?
At the close on Nov 5, 2026: $2.43 (−4.71% on the day). 52-week high: $3.44 on Oct 6, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Pacific Biosciences of California report earnings?
The next quarterly report is on Feb 18, 2027. Last quarter, earnings per share changed +8% year over year, revenue +6%.
Does Pacific Biosciences of California pay dividends?
No, Pacific Biosciences of California does not pay dividends.
Where does Pacific Biosciences of California trade and how to buy it?
Ticker PACB, exchange Nasdaq, listed since 2010. You can buy it through a broker with access to US exchanges.
Should I buy Pacific Biosciences of California now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for PACB are in the terminal after you log in.